EZH2 and hepatocellular carcinoma: The overexpression of p53 was found to increase the expression of miR-15, an inhibitor of OGT expression, to reduce the stability of the enhancer of zeste homolog 2 (EZH2) and the subsequent expression of various oncogenes, thus hindering the progression of HCC in proliferation, migration, and invasion [11].